Fig. 2
From: HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
Wnt/β-catenin signaling and directly related pathways affected by genetic-driven and/or gene expression activation or suppression in primary and/or recurrent tumors of 4 HCC patients. Determination of this pathway as most activated using genetic and genomic data is described in “Patients and methods” while other top ranked pathways are presented in Additional file 1: Table S6. Each of the 4 patients’ primary or recurrent tumors are represented as a quadrant on each pathway node